Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved?

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|16|2956-2963

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.16, 2013-08, pp. : 2956-2963

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inclusion of Older Women in Randomized Clinical Trials: Factors Associated with Taking Study Medication in the Fracture Intervention Trial

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 48, Iss. 9, 2000-09 ,pp. : 1126-1131

John Wiley & Sons Inc

Access to resources Recommend Favorite

A decade of cell therapy clinical trials (2000–2010)

By Culme-Seymour Emily J   Davie Natasha L   Brindley David A   Edwards-Parton Simon   Mason Chris  

Regenerative Medicine, Vol. 7, Iss. 4, 2012-07 ,pp. : 455-462

Future Medicine

Access to resources Recommend Favorite

Assessing benefit in trials: Are we making progress in assessing progression in cancer clinical trials?

By  

CANCER, Vol. 121, Iss. 11, 2015-06 ,pp. : 1728-1730

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary therapy in breast cancer: what have we learned from landmark trials?

By Bozza Claudia   Osa Etin-Osa   Puglisi Fabio  

Women's Health, Vol. 9, Iss. 6, 2013-11 ,pp. : 583-593

Future Medicine

Access to resources Recommend Favorite

What We Have Learned From a Decade of ED Crowding Research

By  

ACADEMIC EMERGENCY MEDICINE, Vol. 22, Iss. 8, 2015-08 ,pp. : 985-987

John Wiley & Sons Inc

Access to resources Recommend Favorite